About

Name

Glen Baker
University

University of Alberta
Website

psychiatry.med.ualberta.ca/AboutUs/DepartmentMembers/Academic/Baker.aspx
Email

[email protected]
Research Keywords

biomarkers in psychiatric and neurological disorders, neurochemistry of depression, schizophrenia and anxiety disorders, drug metabolism and drug interactions, neuroprotective drugs

Additional Information

Lab Methodologies
  • Neurosteroid Assays
  • Amino acid detection
  • Biogenic amines and metabolites including trace amines
  • Radiochemical lab
Apparatus
  • HPLC (fluorimetry, electrochemical, UV detection)
  • HPLC Mass Spectrometry
  • Gas Chromatography Electron Capture detector
  • Gas Chromatography Mass Spectrometry including Triple Quad
  • Liquid Scintillation Counter

 

Roles and Connections

Primary Role

Faculty
CAN Connections

Depression

Most Cited Publications

Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ, "Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis." Journal of neuroinflammation 13,1 (2016 Jun 10): 142
Riske L, Thomas RK, Baker GB, Dursun SM, "Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorder." Therapeutic advances in psychopharmacology 7,2 (2017 Feb): 85-89
MacKay MB, Kravtsenyuk M, Thomas R, Mitchell ND, Dursun SM, Baker GB, "D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?" Frontiers in psychiatry 10, (2019): 25